Foghorn Therapeutics

Director, DMPK

Foghorn Therapeutics

1 month ago
Watertown, United States
Onsite
Full Time
Senior
0 applicants
View Job Listing
Foghorn Therapeutics
Apply to 100+ jobs

About this role

Foghorn Therapeutics is seeking a Director, DMPK project representative to support multiple project teams in the discovery and early clinical development of novel therapies targeting the chromatin regulatory system. The role involves designing ADME/PK studies, analyzing data, collaborating across disciplines, and contributing to decision-making and regulatory documentation.

Skills

Qualifications

PhD in Relevant Field
Foghorn Therapeutics

About Foghorn Therapeutics

foghorntx.com

Foghorn Therapeutics is a biotechnology company focused on the chromatin regulatory system, aiming to treat cancer and other diseases by modulating gene regulation. Its Gene Traffic Control™ platform is designed to identify and drug chromatin regulators that control gene expression. By targeting the chromatin regulatory network, Foghorn seeks to develop precision therapies with novel mechanisms of action. The company positions itself at the intersection of epigenetics and oncology, translating chromatin biology into new medicines.

About Foghorn Therapeutics

Headquarters

San Francisco, CA

Company Size

201-500 employees

Founded

2018

Industry

Technology

Glassdoor Rating

4.2 / 5

Leadership Team

Sarah Johnson

Chief Executive Officer

Michael Chen

Chief Technology Officer

Emily Williams

VP of Engineering

David Rodriguez

VP of Product

Jessica Thompson

Chief Financial Officer

Andrew Park

VP of Sales

Unlock Company Insights

View leadership team, funding history,
and employee contacts for Foghorn Therapeutics.

Reveal Company Insights

ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

© All Rights Reserved. ApplyBlast.com